Nektar Therapeutics (NASDAQ:NKTR)
| 3.19 Delayed Data As of 4:00pm ET |  +0.14 / +4.59%Today’s Change | 3.00 Today|||52-Week Range 18.92 | -76.39% Year-to-Date |
Institutional investors hold a majority ownership of NKTR through the 98.40% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2019, these large investors purchased a net $6.6 million shares.
| Mutual fund holders | 74.00% |
| Individual stakeholders | 3.27% |
| Other institutional | 24.40% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 6/30/2022 | BLACKROCK FUND ADVISORS Bought 4.4 Million shares of Nektar Therapeutics |
| 6/30/2022 | FIRST TRUST ADVISORS LP Bought 3.4 Million shares of Nektar Therapeutics |
| 6/30/2022 | GREAT POINT PARTNERS LLC Bought 3.2 Million shares of Nektar Therapeutics |
Top 10 Owners of Nektar Therapeutics
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Invesco Advisers, Inc. | 19.09% | 35,778,658 | 140,967,913 | -3,634 | -0.01% |
| BlackRock Fund Advisors | 15.21% | 28,508,789 | 112,324,629 | +4,405,338 | +18.28% |
| The Vanguard Group, Inc. | 10.84% | 20,315,590 | 80,043,425 | +1,108,853 | +5.77% |
| PRIMECAP Management Co. | 8.83% | 16,551,322 | 65,212,209 | -510,500 | -2.99% |
| Wellington Management Co. LLP | 6.07% | 11,383,721 | 44,851,861 | 0 | 0.00% |
| SSgA Funds Management, Inc. | 4.66% | 8,728,968 | 34,392,134 | +2,928,666 | +50.49% |
| First Trust Advisors LP | 4.18% | 7,834,551 | 30,868,131 | +3,443,933 | +78.44% |
| Geode Capital Management LLC | 1.74% | 3,253,963 | 12,820,614 | +800,499 | +32.63% |
| Maverick Capital Ltd. | 1.72% | 3,218,382 | 12,680,425 | -1,574,538 | -32.85% |
| Great Point Partners LLC | 1.68% | 3,150,000 | 12,411,000 | +3,150,000 | -- |
Top 10 Mutual Funds Holding Nektar Therapeutics
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Invesco Global Opportunities Fund | 19.09% | 35,770,000 | 140,933,800 | 0 | 0.00% |
| iShares Core S&P Small Cap ETF | 7.35% | 13,773,825 | 54,268,871 | -13,240 | -0.10% |
| Vanguard Health Care Fund | 6.07% | 11,383,721 | 44,851,861 | 0 | 0.00% |
| PRIMECAP Odyssey Aggressive Growt... | 5.52% | 10,338,080 | 40,732,035 | -199,600 | -1.89% |
| Vanguard Total Stock Market Index... | 3.12% | 5,846,571 | 23,035,490 | +245,322 | +4.38% |
| PRIMECAP Odyssey Growth Fund | 2.63% | 4,919,156 | 19,381,475 | -274,400 | -5.28% |
| Vanguard Small Cap Index Fund | 2.51% | 4,709,917 | 18,557,073 | +9,311 | +0.20% |
| iShares Russell 2000 ETF | 2.14% | 4,009,451 | 15,797,237 | +21,483 | +0.54% |
| Vanguard Small Cap Growth Index F... | 1.49% | 2,798,964 | 11,027,918 | +33,348 | +1.21% |
| BB Biotech AG | 1.40% | 2,620,676 | 10,325,463 | 0 | 0.00% |